1. Selection must be made prior to the opening bell on the first trading day of the week. 2. Selection may be changed up to the opening bell. 3. Starting price is the opening price on first trading day of week. 4. Ending price is closing price on last trading day of week. 5. No options or other trading vehicles. Only stocks and ETFs are allowed. 6. Opening prices will be those found at Yahoo Finance. Any disputed opening price will be resolved using the price listed at Yahoo Finance historical quotes
To enter the game:
List your stock's symbol, Long or Short, Company name, what the company does and why you like the selection.
Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. The Company's drug delivery and antisense technology, called DNAbilize, is a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body's enzymes when circulating in vivo, incorporated inside of a neutral charged lipid bilayer. In vivo, the DNAbilize delivered antisense drug substances are systemically distributed across the body to allow for reduction or elimination of proteins in blood diseases and solid organs. Using DNAbilize as a platform for drug manufacturing, the Company has approximately three antisense drug candidates in development to treat a total of over five different cancer disease indications.
kadere.... interesting stock. Bought a few to watch long term (Year) and buy more depending on developments. Short term, you are correct (S). but up a few cents today. (Hope I did not jinx you on the last day of the week).